1. Home
  2. Analysis
  3. Aldactazide
  4. Allegra

Aldactazide and Allegra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 18 people who take Aldactazide and Allegra. Common interactions include death among females, and renal failure among males.

The phase IV clinical study analyzes what interactions people who take Aldactazide and Allegra have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 26, 2023

18 people who take Aldactazide and Allegra together, and have interactions are studied.

What is Aldactazide?

Aldactazide has active ingredients of hydrochlorothiazide; spironolactone. It is used in high blood pressure. Currently, eHealthMe is studying from 1,579 Aldactazide users.

What is Allegra?

Allegra has active ingredients of fexofenadine hydrochloride. It is used in allergies. Currently, eHealthMe is studying from 72,432 Allegra users.

Number of Aldactazide and Allegra reports submitted per year:

Aldactazide and Allegra drug interactions.

Common Aldactazide and Allegra drug interactions by gender *:

female:

  1. Death
  2. Dyspnoea
  3. Abdominal distension
  4. Anaemia
  5. Angina unstable
  6. Arthralgia
  7. Blood cholesterol increased
  8. Cardiac failure congestive
  9. Cardio-respiratory arrest
  10. Cardiomyopathy

male:

  1. Renal failure
  2. Cardiac arrest
  3. Ear infection
  4. Hyperkalaemia
  5. Renal injury
  6. Sudden death
  7. Tubulointerstitial nephritis
  8. Cellulitis
  9. Chronic obstructive pulmonary disease
  10. Circulatory collapse

Common Aldactazide and Allegra drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Death
  2. Cardio-respiratory arrest

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Renal failure
  2. Cardiac arrest
  3. Cardiac failure congestive
  4. Gastric ulcer
  5. Myocardial infarction
  6. Oedema peripheral
  7. Angiopathy
  8. Chest pain
  9. Coronary artery disease
  10. Ear infection

60+:

  1. Chronic kidney disease
  2. Renal failure
  3. Angina unstable
  4. Arthralgia
  5. Blood cholesterol increased
  6. Cardiac failure congestive
  7. Cardiomyopathy
  8. Chronic obstructive pulmonary disease
  9. Chronic sinusitis
  10. Colitis ischaemic

Common conditions people have *:

  1. High Blood Cholesterol: 8 people, 44.44%
  2. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 5 people, 27.78%
  3. Pain: 5 people, 27.78%
  4. Heart Attack: 4 people, 22.22%
  5. Stress And Anxiety: 4 people, 22.22%
  6. Cardiac Disorder: 4 people, 22.22%
  7. Enlarged Prostate: 4 people, 22.22%
  8. Oedema Peripheral (superficial swelling): 4 people, 22.22%
  9. Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 4 people, 22.22%
  10. Gout (uric acid crystals building up in the body): 4 people, 22.22%

* Approximation only. Some reports may have incomplete information.

Do you take Aldactazide and Allegra?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Drug side effects by duration, gender and age:

Common Aldactazide drug interactions:

Browse interactions between Aldactazide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Allegra drug interactions:

Browse interactions between Allegra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on hydrochlorothiazide; spironolactone and fexofenadine hydrochloride (the active ingredients of Aldactazide and Allegra, respectively), and Aldactazide and Allegra (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Aldactazide and Allegra.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.